News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
J. Barrie Ward To Strengthen Cancer Research Technology’s Board Of Directors
August 1, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Cancer Research Technology Limited (CRT) today announced the appointment of Dr J. Barrie Ward as a Non-executive Director.
Twitter
LinkedIn
Facebook
Email
Print
People
Europe
MORE ON THIS TOPIC
Regulatory
Acting CBER, CDER heads become permanent as FDA works to restore stability
September 9, 2026
·
2 min read
·
Tristan Manalac
IPO
2026 IPO stock tracker: How newly public biotechs are performing
September 9, 2026
·
1 min read
·
Gabrielle Masson
Venture capital
Solstice rises with $225M to develop next-gen CTLA-4 drug from China
September 9, 2026
·
2 min read
·
Annalee Armstrong
Funding
Caspian launches with $50M, Lilly support to advance disease-modifying diabetes bet
September 9, 2026
·
2 min read
·
Tristan Manalac
